论文部分内容阅读
M Epstein教授在皇家学会最近的一次会议上报告,一种抗伯基特氏(Burkitt)淋巴瘤和未分化型鼻咽癌的疫苗即将用于人体试验。对于Epstein来说,这是他研究的最终目标。因为在20多年前当他还在米德尔塞克斯医院时就开始了这项
Professor M Epstein at a recent meeting of the Royal Society reported that a vaccine against Burkitt’s lymphoma and undifferentiated nasopharyngeal carcinoma is about to be used in human trials. For Epstein, this is the ultimate goal of his research. Because it was started more than 20 years ago while he was still at Middlesex Hospital